- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03432611
A Smartphone App for Women With Primary Dysmenorrhea (smartAID)
July 30, 2019 updated by: Claudia M. Witt, Charite University, Berlin, Germany
Evaluation of a Smartphone Application for Self Care for Women With Menstrual Pain (Primary Dysmenorrhea): a Randomized Trial
With a randomized, pragmatic study the effectiveness of a smartphone app for menstrual pain in 18-34-year-old women with primary dysmenorrhea will be investigated.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Smartphone apps may be useful to guide and support individuals in self-management strategies.
Primary dysmenorrhea is a very common problem for women.
With a randomized, pragmatic study the investigators aim to evaluate whether a smartphone app for women with menstrual pain is effective in reducing menstrual pain in 18-34-year-old women with primary dysmenorrhea.
For this the investigators compare the complete smartphone app with two control versions of this app.
The complete app provides evidence-based self-care information and instructions for self-acupressure in menstrual pain, the control intervention I includes self-care information, but no instructions for self-acupressure, and control intervention II includes instructions for self-acupressure, but no self-care information.
The investigators aim to observe 594 women with primary dysmenorrhea over 12 menstruation cycles.
The primary outcome is the mean pain intensity on the days with pain during the 6th menstruation after randomization using a numerical rating scale (NRS; 0=no pain; 10=strongest pain imaginable).
Women are eligible when they suffer from primary dysmenorrhea, are between 18 and 34 years old, not pregnant and do not plan to be pregnant within the next 12 months.
Study Type
Interventional
Enrollment (Anticipated)
594
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Daniel Pach, MD
- Phone Number: 004930450529068
- Email: daniel.pach@charite.de
Study Contact Backup
- Name: Iris Bartsch
- Phone Number: 004930450529132
- Email: iris.bartsch@charite.de
Study Locations
-
-
-
Berlin, Germany
- Recruiting
- Charite - Universitatsmedizin Berlin
-
Contact:
- Daniel Pach, MD
- Phone Number: 030450529027
- Email: luna-studie@charite.de
-
Contact:
- Email: luna-studie@charite.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 34 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Female, aged 18-34 years
- Dysmenorrhea, defined as self-reported menstrual cramps or pain during every menstrual cycle which started during the teenage years
- No prior history of a gynecological disease that is known to be a reason for the dysmenorrhea
- Not more than 5 days with menstrual pain outside the menstrual period itself
- Menstruation within the last six weeks and a cycle length of 3 to 6 weeks
- Moderate or severe pain, defined as a score equal to or higher than 6 on a numeric rating scale (NRS, 0 to 10) for the worst pain intensity during the last menstruation
- Informed consent
- Possession of an iPhone
- Willingness and ability to input and share anonymous data through the study app
- The willingness to see a doctor when 1) pain is getting worse than usual, 2) pain medication is not helping, and 3) when the pain is still present well before or well after the period.
Exclusion Criteria:
- Known pregnancy
- Pregnancy already planned for the forthcoming 12 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Complete app
198 women with primary dysmenorrhea who receive an app which includes a self-care information feature and a self-acupressure feature.
|
The self-care feature offers information on self-care for menstrual pain.
The following topics are shown: exercise, dietary supplementation, heating pad/hot water bottle, yoga, and information on when to consult a doctor and how primary dysmenorrhoea is often treated.
Notifications from the app which can be deactivated remind women of surveys and activities.
The acupressure feature offers detailed written and multimedia descriptions of an acupressure used for menstrual pain.
Three acupressure points are described, which should be massaged bilaterally twice a day up to five times a day on the 5 days before menstruation and during menstruation.
Each point should be massaged for 2 minutes.
A timer for the acupressure and notifications from the app which can be deactivated remind women of surveys and acupressure.
|
Active Comparator: Control intervention I
198 women with primary dysmenorrhea who receive an app for menstrual pain which includes the self-care information feature, but not the self-acupressure feature.
|
The self-care feature offers information on self-care for menstrual pain.
The following topics are shown: exercise, dietary supplementation, heating pad/hot water bottle, yoga, and information on when to consult a doctor and how primary dysmenorrhoea is often treated.
Notifications from the app which can be deactivated remind women of surveys and activities.
|
Active Comparator: Control intervention II
198 women with primary dysmenorrhea who receive an app for menstrual pain which includes the self-acupressure feature, but not the self-care information feature.
|
The acupressure feature offers detailed written and multimedia descriptions of an acupressure used for menstrual pain.
Three acupressure points are described, which should be massaged bilaterally twice a day up to five times a day on the 5 days before menstruation and during menstruation.
Each point should be massaged for 2 minutes.
A timer for the acupressure and notifications from the app which can be deactivated remind women of surveys and acupressure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean pain intensity on the days with pain
Time Frame: Daily during the 6th menstruation after randomization
|
The mean pain intensity on the days with pain during the 6th menstruation after randomization using a numerical rating scale (NRS; 0=no pain; 10=strongest pain imaginable).
|
Daily during the 6th menstruation after randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean pain intensity on the days with pain
Time Frame: Baseline; daily during menstruation (1st to 5th and 7th to 12th menstrual cycles)
|
The mean pain intensity on the days with pain during the menstruation 1 to 5 and 7 to 12 after randomization using a numerical rating scale (NRS; 0=no pain; 10=strongest pain imaginable).
|
Baseline; daily during menstruation (1st to 5th and 7th to 12th menstrual cycles)
|
Responder
Time Frame: Daily during menstruation (1st to 12th menstrual cycles)
|
Responder defined as having at least 50% pain reduction on the days with pain
|
Daily during menstruation (1st to 12th menstrual cycles)
|
Number of days with pain (duration of pain)
Time Frame: Daily during menstruation (1st to 12th menstrual cycles)
|
Number of days participants reported pain.
|
Daily during menstruation (1st to 12th menstrual cycles)
|
Days with absence from work, training, or studies
Time Frame: Baseline, end of menstruation (1st to 12th menstrual cycles)
|
Days with absence from work or education because of menstrual pain during previous period.
|
Baseline, end of menstruation (1st to 12th menstrual cycles)
|
Days with pain medication
Time Frame: Daily during menstruation (1st to 12th menstrual cycles)
|
Days with intake of pain medication for menstrual pain during each menstruation
|
Daily during menstruation (1st to 12th menstrual cycles)
|
Adverse reaction
Time Frame: End of menstruation (1st to 12th menstrual cycles)
|
Characteristics of adverse reaction
|
End of menstruation (1st to 12th menstrual cycles)
|
Severe adverse events
Time Frame: End of menstruation (3rd, 6th, 9th, and 12th menstrual cycles)
|
Characteristics and duration of severe adverse events
|
End of menstruation (3rd, 6th, 9th, and 12th menstrual cycles)
|
Frequency of acupressure application
Time Frame: 5 days before menstruation and during menstruation (1st to 12th menstrual cycles)
|
Number of times acupressure was applied during each cycle
|
5 days before menstruation and during menstruation (1st to 12th menstrual cycles)
|
User satisfaction
Time Frame: End of menstruation (1st to 12th menstrual cycles)
|
User's satisfaction with app guided activity (NRS; 0=totally unsatisfied; 6=very satisfied)
|
End of menstruation (1st to 12th menstrual cycles)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Claudia M. Witt, MD, Charite University, Berlin, Germany
- Principal Investigator: Daniel Pach, MD, Charite University, Berlin, Germany
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 19, 2018
Primary Completion (Anticipated)
September 1, 2020
Study Completion (Anticipated)
March 1, 2021
Study Registration Dates
First Submitted
January 18, 2018
First Submitted That Met QC Criteria
February 12, 2018
First Posted (Actual)
February 14, 2018
Study Record Updates
Last Update Posted (Actual)
July 31, 2019
Last Update Submitted That Met QC Criteria
July 30, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- smartAID-18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Dysmenorrhea
-
Cynthia del Rocío Márquez BeltránUniversity of HuelvaActive, not recruitingPrimary Dysmenorrhea | Menstrual Pain | Menstrual Distress \(Dysmenorrhea\)Spain
-
Istanbul Medipol University HospitalNot yet recruiting
-
Cairo UniversityNot yet recruitingPrimary Dysmenorrhea
-
Hacettepe UniversityRecruitingPrimary DysmenorrheaTurkey
-
Tokat Gaziosmanpasa UniversityRecruitingDysmenorrhea | Dysmenorrhea PrimaryTurkey
-
Cairo UniversityNot yet recruitingPrimary Dysmenorrhea
-
Ankara Yildirim Beyazıt UniversityNot yet recruitingPrimary Dysmenorrhea
-
Ankara Yildirim Beyazıt UniversityNot yet recruiting
-
Cairo UniversityCompleted
-
University of ValenciaCompleted
Clinical Trials on Self-care information feature
-
University of British ColumbiaInterior Health; Retired Teachers of Ontario FoundationCompleted
-
Geisinger ClinicCompletedBehavior, HealthUnited States
-
Radboud University Medical CenterUMC Utrecht; St. Antonius Hospital; The Netherlands Cancer Institute; Franciscus... and other collaboratorsCompletedBreast Cancer | Cognitive Decline | Cognitive Symptoms
-
Taipei Medical University WanFang HospitalNo longer availableValuable Suggestions to Improve Health Care Quality Transparent and Accessible Medical Care
-
The University of Texas Health Science Center,...Completed
-
National Taipei University of Nursing and Health...Chang Gung Memorial Hospital; National Science and Technology CouncilRecruitingProstatic Neoplasms | Self-ManagementTaiwan
-
US Department of Veterans AffairsCompleted
-
University of LiegeUnknownComparison of Treatment for Chronic Non-malignant and Malignant PainBelgium
-
University of LiegeCompletedComparison of Different Treatment for Chronic Pain